Outcomes of the 2019 CCIS Meeting

The first Implementation Science Consortium in Cancer (ISCC) meeting focused on developing a new approach to establish an expectation of how the field can work together to address key challenges and identify and develop areas of research that require ongoing relationship and facilitation towards advancing the implementation science agenda in cancer control.

Read a summary of the CCIS meeting (PDF, 3.5 MB)

Welcome, Overview of Implementation Science, and Day 1 Panel

The welcome address by Dr. Robert Croyle began with a brief history of implementation science (IS) at NCI. He expressed a need for a high level of theoretical and methodological rigor within the field, with expectations for the IS community to provide ongoing mentoring and technical assistance.

Dr. Chambers then gave an overview of IS at NCI in recent years, along with an introduction to the purpose and intended outcomes of an Implementation Science Consortium in Cancer. NCI planned the consortium to bring together a diverse community to think about “public goods” for implementation science in cancer, with an emphasis on inclusivity, transparency, strategy, and efficiency.

The Day 1 panel focused on whether the existing “research to practice” pathway successfully enables the optimization of evidence-based cancer control within clinical and community settings. The discussion frequently referenced the importance of stakeholder engagement, suggesting identification of shared goals and priorities in its approach. It emphasized the need for training more people in IS and policy to help advance cancer research.


  • Robert Croyle — National Cancer Institute
  • David Chambers — National Cancer Institute
  • Rinad Beidas — University of Pennsylvania
  • Rani Elwy — Brown University
  • Karen Emmons — Harvard T.H. Chan School of Public Health
  • Russell Glasgow — University of Colorado School of Medicine Denver

Day 2 Panel: Building Capacity for Implementation Science: Considering Implementation Laboratories

Noah Ivers kicked of the Day 2 panel by sharing his experience with implementation science laboratories. He shared the potential for IS laboratories to help with progress in the area of audit and feedback strategies, which he believes leads to less research waste. He suggested that researchers must invest in and commit to relationships, and that mutually beneficial partnerships between researchers and organizational stakeholders will lead to sustainable and scalable interventions.

The panel discussion concentrated on building capacity within clinical and community sites to establish “laboratories” for implementation science. It is important to understand where the community fits in clinical settings and understand that IS also happens outside of clinics. Creating long-term relationships between researchers and communities leads to long-term growth in the field. Additional comments made by panelists focused on funding and health equity.


  • Noah Ivers — Women’s College Hospital, University of Toronto
  • Amy Kilbourne — VA Ann Arbor Healthcare System
  • Simon Craddock Lee — UT Southwestern Medical Center
  • Melissa Simon — Northwestern University

Day 3: Breakout Sessions and Q&A

The third day culminated in presentations from the breakout sessions of project ideas developed during Days 1 and 2 and ended with a full proceedings overview that allowed for a question-and-answer session and participant input on the meeting record. Three main questions posed by NCI to the attendants of the meeting were (1) How shall we advance this consortium? (2) How did participants like the way the event was structured? and (3) What are opinions on the mix of participants?


  • Mindy Clyne — National Cancer Institute
  • Margaret Farrell — National Cancer Institute
  • Rita Kukafka — Columbia University, Dept. Biomedical Informatics
  • Rachel Shelton — Columbia University Mailman School of Public Health
  • Heather Taffet Gold — NYU Langone Health
  • Bob Vollinger — National Cancer Institute

Steering Committee

Prajakta Adsul, MBBS, MPH, PhD
National Cancer Institute

Sarah Bruce Bernal, MA
National Cancer Institute

David Chambers, DPhil
National Cancer Institute

Mindy Clyne, MHS, CGC
National Cancer Institute

Graham Colditz, DrPH, MD, MPH
Washington University in St. Louis

Karen Emmons, PhD
Harvard T.H. Chan School of Public Health

Michael Fiore, MD, MPH, MBA
University of Wisconsin School of Medicine and Public Health

Russell Glasgow, PhD, MS
University of Colorado School of Medicine

Muin Khoury, MD, PhD
Centers for Disease Control

Brian Mittman, PhD
Kaiser Permanente Southern California

Gila Neta, PhD, MPP
National Cancer Institute

Wynne Norton, PhD
National Cancer Institute

April Oh, PhD, MPH
National Cancer Institute

Alanna Kulchak Rahm, PhD, MS, LGC

Donna Shelley, MD, MPH
NYU Langone Health

Rachel Shelton, ScD, MPH
Columbia University, Mailman School of Public Health

Jasmin Tiro, PhD
UT Southwestern Medical Center

Robin Vanderpool, DrPH, CHES
University of Kentucky, College of Public Health

Cynthia Vinson, PhD, MPA
National Cancer Institute

Bryan Weiner, PhD
University of Washington

Stephanie Wheeler, PhD, MPH
University of North Carolina, Chapel Hill

Last Updated
October 27, 2022